Cartesian Therapeutics Inc (NAS:RNAC)
$ 18.83 0.92 (5.14%) Market Cap: 478.56 Mil Enterprise Value: 274.02 Mil PE Ratio: 0 PB Ratio: 607.42 GF Score: 52/100

Q4 2018 Selecta Biosciences Inc Earnings Call Transcript

Mar 15, 2019 / 12:30PM GMT
Release Date Price: $65.1 (-2.25%)
Operator

Thank you for holding. Welcome to the Selecta Biosciences Fourth Quarter and Full Year 2018 Financial Results Conference Call. (Operator Instructions) This call is being webcast live on the Investor and Media section of Selecta's website at www.selectabio.com, and it is being recorded.

For opening remarks, I would now like to turn the call over to John Leaman, Selecta's Chief Financial Officer and Head of Corporate Strategy. Please go ahead, sir.

John H. Leaman
Selecta Biosciences, Inc. - CFO, Head of Corporate Strategy & Treasurer

Thank you, Keith, and good morning, everyone. Earlier today, we issued a press release containing our fourth quarter and full year 2018 financial results and other corporate updates, and we expect to file our 10-K post-market this afternoon. This release and the 10-K, when filed, can be accessed by visiting our website at www.selectabio.com.

I'm joined today by Carsten Brunn our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot